Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
E-pub ahead of print

Pulmonary arterial enlargement in well-treated persons with HIV

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Interstitial lung abnormalities in people with HIV infection and uninfected controls

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Soluble Markers of Interleukin 1 Activation as Predictors of First-Time Myocardial Infarction in HIV-Infected Individuals

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Prevalence and incidence of various Cancer subtypes in patients with heart failure vs matched controls

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Self-reported health status and the associated risk of mortality in heart failure: The DANISH trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Differences in mortality in patients undergoing surgery for infective endocarditis according to age and valvular surgery

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Fractional Flow Reserve Guided PCI in Patients With and Without Left Ventricular Hypertrophy: a DANAMI-3-PRIMULTI Sub-study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

BACKGROUND: Pulmonary artery enlargement is a marker of pulmonary hypertension. We aimed to determine the proportion with pulmonary artery enlargement among well-treated persons with HIV (PWH) and uninfected controls.

METHODS: PWH with a chest computed tomography were included from the ongoing Copenhagen Comorbidity in HIV Infection (COCOMO) study. Age and sex-matched uninfected controls were recruited from the Copenhagen General Population Study. Pulmonary artery enlargement was defined as a ratio of the diameter of the main pulmonary artery at the level of its bifurcation divided by the diameter of the ascending aorta (PA:A)>1.

RESULTS: In total, 900 PWH were included and 44 (5%) had PA:A>1. After adjusting for age, sex and BMI, obesity (adjusted odds ratio, aOR: 4.33 [1.76-10.65], p=.001) and intravenous drug use (aOR: 4.90 [1.00-18.46], p=.027) were associated with higher odds of PA:A>1. Pulmonary indices or smoking were not associated with PA:A>1. HIV seropositivity was borderline associated with PA:A>1 (aOR: 1.89 [0.92-3.85], p=.081).

CONCLUSIONS: PA:A>1 was common in PWH. Obesity and intravenous drug use were independently associated with PA:A>1, but HIV-related factors were not. HIV serostatus was borderline associated with PA:A>1. Increased awareness may be appropriate in obese PWH and in those with intravenous drug use.

OriginalsprogEngelsk
TidsskriftThe Journal of infectious diseases
ISSN0022-1899
DOI
StatusE-pub ahead of print - 19 jun. 2020

Bibliografisk note

© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

ID: 60097395